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Abstract
Complementary and alternative medicine (CAM) is garnering increasing interest and acceptance among the general 
population throughout the world. The use of CAM by cancer patients is very common in China. The referenced English 
literature has no rural community-based study from China on this subject. This study was conducted to define the prevalence, 
pattern of use, and reasons for using CAM by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital 
(ZUTH-ZJH), China. Face-to-face interviews using a structured questionnaire were used to determine the use of CAM by 
cancer patients. All consenting cancer patients were interviewed as they presented at the Department of Surgical Oncology of 
ZUTH-ZJH, from September 2009 to February 2010. One hundred and twenty one patients were interviewed; 64 (52.9%) 
were males and 57 (47.1%) were females. One hundred and thirteen patients (93.4%) have used CAM at some time during 
their current cancer illness, fifty two (46.0%) are female and sixty one (54.0%) are male patients; 8 (6.6%) patients have not 
used any form of CAM. Chinese medicine (73.5.0%) was the most commonly reported CAM modality. Over 71.7% of those 
who used CAM were satisfied, only 28.3% were disappointed. Twenty eight users (24.8%) did not see any benefit from the 
CAM, but eighty one patients (71.7%) could describe some specific benefits. Only one patient will use orthodox medicine 
instead of CAM in the future, almost all patients will continue to use CAM in the future. CAM use is very common among 
cancer patients in local area of China. Most users obtain the expected benefits, and adverse events are uncommon. It is 
imperative that oncologists should explore the use of CAM with their cancer patients and work towards an integrated model 
of health-care provision. This knowledge will enable oncologists to better counsel the patients.
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Introduction
Complementary and alternative medicine (CAM) has been defined as ‘any diagnosis, treatment or prevention that 
complements mainstream medicine by contributing to a common whole, by satisfying a demand not met by orthodoxy or by
diversifying the conceptual framework of medicine’ (Ernst et al., 1995; Ernst, 1995). CAM includes a wide range of therapies. 
The National Center for Complementary and Alternative Medicine in the USA classifies CAM therapies into five categories 
(National Center for Complementary and Alternative Medicine, 2004): alternative medical systems, such as traditional 
Chinese medicine or Ayurveda; mind-body interventions, such as meditation, prayer, healing or support groups; biologically 
based therapies, such as herbs, dietary supplements or vitamins; manipulation and body-based methods, such as massage,
chiropractic or osteopathy; and energy therapies, such as Qi Gong, Reiki, and magnetic fields).
The use of CAM has increased steadily over the past decades, and it has gained medical, economic and
sociological importance in Western countries (Ernst and Cassileth, 1998). However, as the bulk of the literature comes from 
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the Western countries (Oneschuk et al., 1998; Kelly et al., 2000; Richardson et al., 2000; Sparber, et al., 2000; Bernstein and
Grasso, 2001; Cassileth et al., 2001; Jordan and Delunas, 2001; Patterson et al., 2002; Swisher et al., 2002; Molassiotis and 
Cubbin, 2004), little is known about the use of CAM in cancer patients specifically in rural area of China. The aim of the 
present study was to assess the prevalence, pattern of use, and reasons for using CAM by cancer patients at Zhejiang 
University College of Medicine Teaching Hospital Zhuji Hospital (ZUTH-ZJH), China.
Patients and methods
Patients and settings
This was a cross-sectional study involving the direct administration of questionnaires to all cancer patients seen at 
the Department of Surgical Oncology of ZUTH-ZJH, from September 2009 to February 2010. Patients were included if they 
met the following inclusion criteria: they were adult patients of either gender with a diagnosis of cancer; aware of their 
diagnosis; able to understand the questions; free from any condition that would make completing the questionnaire
inappropriate or overburdening for the patients; and they were willing to participate in the study.
Procedures
Three interviewers (nurses) were trained to administer the questionnaire throughout the study. The questionnaire 
was anonymous and was handed out to the patients after they received information about the study, agreed to participate and
signed the consent form. Patients completed the questionnaire while they were resting at the wards to be seen by the nurses. 
On completion, patients handed the questionnaire to the nurse. The patients were informed that they were free to decline 
answering any question with which they were not comfortable. Physicians who were in any way involved in the treatment of 
each patient were not present during the interview.
The questionnaire
The questionnaire used was based on the one developed by Swisher et al (Swisher et al., 2002). However, the 
questionnaire was modified for the purposes of the present study. The questionnaire included demographic data, such as age, 
sex, marital status, socioeconomic status, occupation, insurance coverage, and highest level of education attained. Questions 
were asked about the type of cancer, previous treatments received, and the treatment that the patient was currently receiving.
If patients reported no past or current use of CAM during their cancers after completing the demographic and clinical section 
of the questionnaire, they were thanked for their contribution and asked to stop completing the questionnaire at that stage. If 
patients reported past or current use of CAM during their cancers, they were asked to continue.
In the rest of the questionnaire, each patient was presented with a list of known CAM remedies. The patient was 
asked whether he/she had used any of them during his/her cancer. Patients who had used CAM at least once during the study 
were regarded as CAM users; non-users had not used CAM at all during his/her cancer. Those who had used CAM 
previously in their lives but not currently using were also considered nonusers. CAM practices and therapies presented to the
patients included: alternative medical systems (Chinese medicine, acupuncture, homeopathy, ritual sacrifice, 
divination/incantations, specified folk remedies, et al); mind-body interventions (massage, manual healing/therapeutic touch, 
mind-body technique, hypnosis, visualization/vision, meditation, and faith healing/prayer house healing, etc), 
biologically-based treatments (herbal drugs, high dose/mega vitamins, forever living products, aloe vera, medicinal tea, green
tea, special diets/nutritional therapies, mineral therapy, animal extracts, python fat, etc), manipulative and body-based 
methods (bloodletting/coup, chiropractics, osteopathy/bone setting, et al) and energy therapy (bioelectromagnetics, oxygen 
therapy, et al). CAM users were asked how frequently they used CAM, how they got the provision about the CAM, what 
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useful effect they were hoping to get from CAM (reasons for using CAM), how they had actually benefited from the CAM, 
what ill effects or side-effects they suffered from using the reported CAM therapy, and how much money they had spent on 
CAM therapy. They were asked if they had discontinued or hoped to discontinue CAM. Finally, the patients were asked 
whether their doctor knew they were using or had used CAM, and whether they perceived any impediments to discussing 
their use of CAM freely with their doctor.
Statistical analysis
   The data were analyzed using Statistical Package for Social Sciences (SPSS) software version 16.0. Descriptive 
statistics were calculated with all variables to summarize the data. Difference between reasons for using CAM and perceived 
benefits from its use was assessed using the Chi-square test.
Results
Demographic and clinical characteristics of the sample
One hundred and twenty five patients were invited to participate in the study. One hundred and twenty one patients
(96.8%) patients were interviewed; 64 (52.9%) were males and 57 (47.1%) were females. One hundred and thirteen patients 
(93.4%) have used CAM at some time during their current cancer illness; fifty two (46.0%) were female and sixty one
(54.0%) were male patients. Their mean age was 57.31 years [range 19-85; standard deviation (SD) 12.78]. Patient’s
demographic and clinical characteristics are outlined in Table 1. Lung, gastric, breast, colorectal, and liver cancers
predominated.
The prevalence and patterns of CAM use
Table 2 shows the patterns and prevalence of CAM therapies used by cancer patients. One hundred and thirteen 
patients (93.4.0%) reported having used at least one form of CAM therapy after cancer diagnosis; 8 (6.6%) patients have not 
used any form of CAM. Chinese medicine (73.5.0%) was the most commonly reported CAM modality. Sixteen patients used 
psychological techniques such as faith healing (14.2%).
The most common provider of CAM was traditional Chinese medicine doctors (38.1%) followed by family
members (33.6%) and friends (24.8.0%). Fifty eight patients (51.3%) visited a CAM provider once a month and fourteen 
patients (12.4%) visited a CAM provider 1-2 times a week. Furthermore, thirty two patients (28.3%) visited a CAM provider
almost daily. Eighty four patients (74.3%) using CAM had informed their oncologist and believed it was important 
information for their oncologist to know. Twenty nine patients (25.7%) did not mention their use of CAM to their doctors, 
mostly because the doctor did not ask.
Reasons for using CAM and perceived benefits from its use
We further examined patients’ reasons for using CAM therapy and their perceived benefits experienced by the use 
of CAM therapy (Table 3). Most patients were using CAM as they wanted to increase their body’s ability to fight the disease 
or to assist the body’s natural forces to heal or to boost body’s immune system (44.2%), directly treat or cure the cancer or  
decrease tumor (38.1%), improve physical well-being or increase quality of life (29.2%), or relieve cancer symptoms (26.5%).
However, the benefits from using CAM didn’t satisfy the patients’ reasons for using CAM. In more detail, although the 
primary reason stated for using CAM was to increase the ability to fight the cancer, only twenty patients (17.7%) found CAM 
of benefit (P <0.001). And although the reason stated for using CAM was to directly treat or cure the cancer, only seven 
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Table 1: Demographic and clinical characteristics of the samples
Parameter n %
Sex Male 61 54.0
Female 52 46.0
Marital status Married 104 92.0
Single 2 1.8
Widowed/ Divorce/ Separated 7 6.2
No response 0 0
Education level Illiterate 2 1.8
Primary education 55 48.7
Secondary education (high school) 52 46.0
College/University education 4 3.5
Annual income of family (RMB) Low income (<50,000) 48 42.5
Middle income (50,000-100,000) 21 18.6
High income (>100,000) 44 39.0
Occupation Retired 19 16.8
Educational profession 2 1.8
Managerial profession 6 5.3
Manual worker 12 10.6
Housewife 14 12.4
Peasant 58 51.3
Unemployed 2 1.8
Primary Cancer Lung cancer 26 23.0
Gastric cancer 18 15.9
Breast cancer 16 14.2
Colorectal cancer 16 14.2
Liver cancer 12 10.6
Gynecological cancers 7 6.2
Hematological cancers 5 4.4
Pancreatic cancer 5 4.4
Head and neck caner 4 3.5
Genitourinary cancers 1 0.9
Bone/spine cancer 1 0.9
Malignant melanoma 1 0.9
Brain tumors 1 0.9
Past treatment received Surgery alone 19 16.8
Chemotherapy 20 17.7
Radiotherapy 0 0
Surgery and chemotherapy 52 46.0
Chemotherapy and radiotherapy 6 5.3
Surgery, chemotherapy and radiation 3 2.7
Other combinations 13 11.5
Currently receiving treatment Surgery alone 0 0
Chemotherapy 60 53.1
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Table 1 Continued: Demographic and clinical characteristics of the samples
Parameter n %
Radiotherapy 2 1.8
Surgery and chemotherapy 0 0
Chemotherapy and radiotherapy 5 4.4
Surgery, chemotherapy and radiation 0 0
Other combinations 46 40.7
patients (6.2%) found CAM of benefit (P <0.001). Additionally, it is interesting to note that forty four patients (38.9%) found 
CAM to be helpful in relieving cancer symptoms, although this was only identified as a reason for use in 26.5% of the sample
(P <0.05).
Over 71.7% of those who used CAM were satisfied, only 28.3% were disappointed. Twenty eight users (24.8%) 
did not see any benefit from the CAM, but eighty one patients (71.7%) could describe some specific benefits. Only one 
patient will use orthodox medicine instead of CAM in the future, almost all patients will continue to use CAM in the future.
Ill effects or side-effects from using CAM therapy
As shown in Table 4, eight patients (7.1%) reported side-effects from the CAM therapy they had used. Most 
seemed to be transient side-effects and they were all related to ingesting herbs. These side-effects included stomach aches;
gastric upset and nausea; itching; headaches and migraine; and diarrhoea.
Discussion
To the best of our knowledge, this is the first community-based study of the use of CAM therapies by cancer 
patients from rural area of China. Up-to-now, only Cui et al. (2004) and Chen et al. (2008) reported the use of CAM by 
cancer patients in China. Both of the studies assessed the prevalence, pattern of use, and reasons for using CAM by breast 
cancer patients. The patients included in the two studies were both from urban Shanghai but not from rural area of China.
The prevalence of CAM use among all cancer patients varies widely. Figures have ranged from 7% to 83% (Ernst
and Cassileth, 1998; Sparber and Wootton, 2001), but the average rate across adult studies has been 31.4% (Ernst and
Cassileth, 1998). Our own prevalence rate of 93.4% is one of the highest reported in the literature. While the definition of
what is considered CAM therapy in each study accounts for some of these variations, we hypothesized that the high 
prevalence rate among our patients might be explained by the traditional nature of our society, the Chinese cultural and 
religious beliefs and practices, and the high cost of western conventional treatment. Though there is no English literature
from mainland of China which can support our hypothesis, the finding of Roth and Kobayashi (2008) might give us some 
evidence. Their finding indicated that cultural factors played a key role in establishing the necessary conditions for increasing 
the likelihood of CAM use for Chinese Canadians. The high prevalence rate of CAM use in mainland of China may also 
partially due to the high insurance coverage of CAM. In China, especially in Zhejiang province, there is a sound ‘Cooperative 
Medical System’, medical expenses of using CAM has a compensation rate of 40% of total medical cost, while compensation
rate for Western medicine is 20%.
In our study, the most commonly used form of CAM in China is Chinese medicines and specified folk remedies, 
followed by faith healing/prayer house healing. Notwithstanding the current emphases on Western medicine in China, CAM 
is still one of the mainstream ways to treat diseases and ailments for many Chinese cancer patients. While the two systems
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Table 2: Patterns of CAM used by patients (n = 113)
Alternative medical systems Frequency of use n (%)
Chinese medicine 83 (73.5)
Specified folk remedies 22 (19.5)
Divination/incantations 10 (8.8)
Mind-body interventions
Faith healing 16 (14.2)
Prayer house healing 8 (7.1)
Healing or support groups 6 (5.3)
Autogenic training 4 (3.5)
Psychic therapies 1 (0.9)
Relaxation therapy 1 (0.9)
Tai Chi 1 (0.9)
Biologically-based therapies
Forever living products 51 (45.1)
Special diets/nutritional therapies 36 (31.9)
Herbs 16 (14.2)
Dietary supplements (animal extracts/ coenzyme Q10/ 
Python fat)
10 (8.8)
Medicinal tea 5 (4.4)
Aloe vera 2 (1.8)
Vitamins 1 (0.9)
Green tea 1 (0.9)
Aromatherapy 1 (0.9)
Oxygen therapy 1 (0.9)
Manipulation and body-based methods
Massage 2 (1.8)
Tui-na 1 (0.9)
Energy therapies 0 (0)
CAM providers
Traditional Chinese medicine doctors 43 (38.1)
Western medicine doctors 4 (3.5)
Family members 38 (33.6)
Friends or others 28 (24.8)
run parallel in the Chinese environment, switching from one form to the other is a common phenomenon and depends on 
which of them is more suitable for a particular condition. Just as Fan and Holliday (2007) suggested that a proper integrative 
system for CAM and Western medicine should be a dual standard based system in which both CAM and Western medicine
are free to operate according to their own medical standards. In addition, most of Chinese cancer patients die even after 
receiving conventional western medical treatment. This gives people the impression that conventional western medical 
treatments may be not better than CAM. Subsequently, it makes sense for them to try CAM first or second, or to use CAM in 
combination with Western medicine to get all the benefits possible.
Conflicting findings have been reported about factors that affect the use of CAM therapies (Ernst and Cassileth, 
1998; Sparber, et al., 2000; Jordan and Delunas, 2001; Swisher et al., 2002; Molassiotis and Cubbin, 2004). With respect to 
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Table 3: Reasons for using CAM therapy and benefits experienced by the use of CAM therapy (n = 113)
Reasons for using CAM therapy n % Benefits experienced by the use of 
CAM therapy
n % p
To boost or increase body’s ability to 
fight cancer / To assist the body’s
natural forces to heal / To boost 
body’s immune system
50 44.2 Boosted or increased body’s ability 
to fight cancer / Assisted the body's
natural forces to heal / Boosted
body’s immune system
20 17.7 a
‘Might help, can’t hurt’ 46 40.7 No hurt 47 41.6 b
To decrease tumor / To directly 
treat/cure the cancer
43 38.1 Decreased tumor 7 6.2 a
To improve physical well being/ To 
increase quality of life
33 29.2 Improved physical well being/ 
Increased quality of life
25 22.1 b
To relieve cancer symptoms 30 26.5 Relieved cancer symptoms 44 38.9 c
Requested by physician 25 22.1
Perfectly safe 22 19.5
To improve psychological and 
emotional well being, provide hope 
and increase optimism
17 15.0 Improved psychological and 
emotional well being, provided hope 
and increased optimism
17 15.0 b
To prevent spread of cancer/ To 
prevent recurrence of cancer
10 8.8
To assist other treatments 9 8.0 Assisted other treatments 3 2.7 b
Desire to do everything possible to
fight the disease
3 2.7
No response 0 0 No response 1 0.9 b
a, P <0.001; b, P >0.05; c, P <0.05.
Table 4: Ill effects or side-effects from using CAM therapy (n = 113)
Ill effects or side-effects n %
No side-effects or uncomfortable feeling 102 90.3
With side-effects but hope to continue CAM treatment 7 6.2
With obvious side-effects and hope to discontinue CAM treatment 1 0.9
No response 3 2.7
Stomach aches 3 2.7
Gastric upset and nausea 2 1.8
Itching 1 0.9
Headaches and migraine 1 0.9
Diarrhoea 1 0.9
other CAM surveys in rural settings, for example, Ben-Arye E et al (Ben-Arye, et al., 2009) reported that women used CAM 
more often than men did and Jewish women used CAM more often than Arab women did. While we found there was no 
association between use of CAM and age, marital status, or socioeconomic status in our patients. Most of our patients 
expected CAM to increase their body’s ability to fight the disease or to assist the body’s natural forces to heal or to boost 
body’s immune system (44.2%), to directly treat or cure the cancer or decrease tumor (38.1%), to improve physical 
well-being or increase quality of life (29.2%), or to relieve cancer symptoms (26.5%).CAM users in China mainly rely on 
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CAM doctors for their information about CAM. Patients seem to be satisfied with the use of CAM, even if they do not see 
any obvious benefit from it. A wide range of reasons contribute to the use of CAM, and perhaps the concept of ‘hope’ is 
fundamental in each one of these reasons. Those who used CAM to improve physical and emotional well-being seemed to 
have benefited from CAM. These findings coincide with findings from the USA (Swisher et al., 2002).
Only 7.1% of patients reported ill effects or side-effects from CAM which supported the assumption that these 
agents are safe. In other side, it is very difficult to distinguish from the natural manifestations or progression of advanced 
cancers.
Some of our patients (25.7%) who used CAM did not tell their doctors about it. The fact that these patients will not 
disclose their use of CAM unless asked makes it necessary for every oncologist to routinely ask his/her cancer patients 
whether they use CAM, the patterns they use, and the reasons they use them.
There were several limitations to our study. Our sample size of 121 was small. We were not able to generalize to
the entire cancer population because we limited the study sample to patients who were receiving treatment at our teaching 
hospital. However, a national cancer registry-based study would fully describe differences in behavior that may be linked to 
specific demographic characteristics.
Conclusion
The prevalence of CAM use in cancer patients in rural area of China is one of the highest in the world. Chinese
medicines and specified folk remedies, and faith healing/prayer house healing are the most common forms of CAM. Most of 
the cancer patients expected to be cured by using CAM. Some of the patients who used CAM were not willing to mention
that information to their doctors. We believe that clinical oncologists should be aware of the prevalence of use of CAM in 
his/her environment. Patients should routinely be asked about CAM use as part of every cancer patient’s evaluation.
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